Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers

Giulia Bon, Rossella Loria, Carla Azzurra Amoreo, Alessandra Verdina, Isabella Sperduti, Arianna Mastrofrancesco, Silvia Soddu, Maria Grazia Diodoro, Marcella Mottolese, Matilde Todaro, Giorgio Stassi, Michele Milella, Ruggero De Maria Marchiano, Rita Falcioni

Research output: Contribution to journalArticle

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science